VV116

Products

Inquiry

Cat. No.: IBDI-431897

VV116 (JT001) is a deuterated version of Remdesivir (HY-104077), a highly orally active nucleoside antiviral against SARS-CoV-2 and respiratory syncytial virus (RSV). VV116 retains the antiviral activity of Remdesivir against COVID-19, and is the first domestically produced deuterium targeting the COVID-19.

Size (Solid):

Product Details

Target	SARS-CoV \| RSV \| Influenza Virus
Molecular Weight	583.45
Appearance	Solid
Synonyms	JT001, GS-621763-d1 hydrobromide
SMILES	[H]Br.N#C[[email protected]](O[[email protected]@H]1COC(C(C)C)=O)(C2=CC([2H])=C3N2N=CN=C3N)[[email protected]@H]([[email protected]@H]1OC(C(C)C)=O)OC(C(C)C)=O
Purity	99.46%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.

! For research use only, not intended for any clinical use.